- Home
- »
- Nutraceuticals & Functional Foods
- »
-
Nicotinamide Adenine Dinucleotide Supplements Market Report 2033GVR Report cover
Nicotinamide Adenine Dinucleotide Supplements Market (2026 - 2033)
Size, Share & Trends Analysis Report By Form (Capsules/Tablets, Gummies, Powders), By Distribution Channel (Hypermarkets & Supermarkets, Pharmacies & Drug Stores), By Region, And Segment Forecasts
Market Size, 2025
$2.8BMarket Estimate, 2026
$3.2BMarket Forecast, 2033
$8.5BCAGR, 2026–2033
14.8%Nicotinamide Adenine Dinucleotide Supplements Market Summary
The global nicotinamide adenine dinucleotide supplements market was valued at USD 2.8 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 8.5 billion by 2033, at a CAGR of 14.8% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 49.0% in 2025. Growth is supported by increasing consumer interest in healthy ageing, cellular energy production, and preventive wellness, driving demand for NAD+ boosters such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By form: Capsules/ tablets supplements segment held the largest share of 61.1% in 2025.
- By distribution channel: Online channel held the largest share of 48.3% in 2025.
Regional Highlights
- Largest Region: Asia Pacific (49.0% revenue share, 2025)
- Fastest-growing regional market: Middle East & Africa (highest CAGR, 2026-2033)
- By country: China held the largest market share in 2025.
Key Market Trends & Insights
- Market size in 2025: USD 2.8 Billion
- Estimated market size in 2026: USD 3.2 Billion
- Projected market size by 2033: USD 8.5 Billion
- CAGR (2026-2033): 14.8%
Prism AI by Grand View Research Free to tryAsk a question about the nicotinamide adenine dinucleotide supplements marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →Manufacturers are also expanding product portfolios through advanced formulations, combination supplements, and convenient delivery formats to attract health-conscious consumers. Additionally, advancements in supplement formulations are expanding the availability of NAD-related products across diverse consumer segments. Growing investment in research and development is supporting the introduction of innovative delivery formats and improved formulations. The expansion of e-commerce and specialized health and wellness retail channels is also improving product accessibility and supporting market penetration. In August 2026, Niagen Bioscience expanded Tru Niagen’s retail presence through GNC and Sam’s Club, reaching nearly 300 locations across 44 U.S. states and offering multiple product formats.
To learn more about this report,Download Free Sample Report
Furthermore, increasing interest in personalized nutrition is creating opportunities for NAD products tailored to individual health and lifestyle needs. In addition, growing awareness of nutrition-based approaches to maintaining healthy aging is encouraging consumers to explore specialized supplementation options. Greater consumer focus on targeted wellness solutions is also supporting demand for specialized nutraceutical products.
Market Dynamics
Consumers are increasingly seeking solutions that support well-being throughout the aging process. This shift is encouraging interest in nutraceuticals positioned around maintaining vitality and long-term wellness. According to an article published by Univar Solutions, the global population aged 65 and above is projected to reach approximately 1 billion, or 12% of the world’s population, by 2030, up from around 585 million nearly a decade earlier. Nicotinamide adenine dinucleotide supplements are gaining attention within this broader preventive wellness landscape. The trend is particularly relevant among consumers looking for alternatives that complement their daily health routines. As longevity becomes a more prominent wellness theme, demand for specialized supplements can continue to expand.
Nicotinamide adenine dinucleotide supplements face varying regulatory requirements depending on the country or region in which they are marketed. Differences in ingredient classification, permissible claims, labeling, and safety requirements can complicate product commercialization. Companies may therefore need to adapt their formulations and marketing strategies to meet local requirements. Such variations can increase compliance complexity and extend the time needed for market entry. Unclear or evolving regulations may also create challenges for companies seeking consistent international expansion.
Innovation in delivery systems can create opportunities to improve how NAD-related ingredients are incorporated into supplement products. Companies can explore formats designed to enhance stability, convenience, and consumer usability. These developments may help differentiate products in an increasingly specialized nutraceutical market. Research into alternative delivery approaches can also support the creation of products suited to different consumer preferences. Continued technological development could therefore broaden the range of NAD supplement offerings. In June 2026, Gundry MD launched Elevate NAD+, an NMN supplement featuring patent-pending acid-resistant beadlet technology designed to improve NMN stability during storage and digestion.
Analyst Perspective
The global nicotinamide adenine dinucleotide supplements market is developing as consumer interest in healthy aging, cellular energy, and longevity-focused nutrition increases. Growing awareness of NAD precursors such as NR and NMN is encouraging product adoption, while advancements in formulation and delivery formats are broadening consumer choices. Online platforms are improving accessibility, whereas specialty and practitioner-led channels contribute to product education and premium positioning. Competition is increasingly influenced by scientific evidence, ingredient quality, formulation innovation, and brand credibility. Future market development will depend on regulatory clarity, clinical validation, consumer awareness, and continued product differentiation.
Form Insights
The NAD capsules/ tablets market accounted for the largest share of 61.1% of the revenue in 2025. Capsules and tablets are driven by consumer familiarity with conventional dietary supplements and their straightforward daily-use format. They allow manufacturers to provide standardized doses of NMN, NR, NADH, or combination formulations in a compact serving. These formats are well suited to online sales, specialty nutrition stores, pharmacies, and health-practitioner channels. Protective coatings, beadlets, and controlled-release technologies can help improve the stability of sensitive NAD-related ingredients. The availability of established products such as Tru Niagen through major specialty retailers further strengthens consumer confidence in oral solid formats.
To learn more about this report,Download Free Sample Report
The NAD gummies market is projected to grow significantly at a CAGR of 15.3% from 2026 to 2033. Gummies are gaining attention because they offer a more enjoyable and palatable alternative to swallowing capsules or tablets. Their soft texture and flavored format may attract younger consumers and individuals who have difficulty taking pills. Brands can use gummies to introduce NAD-related ingredients to broader healthy-aging, beauty, energy, and wellness audiences. The format also supports social-media-led product discovery because its appearance and taste are easier to communicate in short-form content. In September 2026, Vitafusion introduced its Vital NMN Gummies in a Tropical Glow flavor, delivering 300 mg of NMN per serving to promote NAD+ levels, cellular wellness, energy, and metabolic health. The “Aging? Love It.” TikTok-led campaign focuses on younger health-conscious audiences and presents gummies as an easy-to-use alternative to conventional NMN capsules.
Distribution Channel Insights
The sales of nicotinamide adenine dinucleotide supplements through online channels account for the largest share of 48.3% of the global revenue in 2025. Online distribution is driven by the convenience of home delivery and the growing preference for digital purchasing of health supplements. Consumers can easily compare NAD supplement formulations, prices, ingredients, and customer reviews across multiple platforms. E-commerce also enables brands to reach consumers beyond physical retail locations, supporting wider market penetration. Subscription models, promotional offers, and personalized recommendations can encourage repeat purchases. Increasing consumer familiarity with online health and wellness shopping further supports the channel’s expansion.
To learn more about this report,Download Free Sample Report
The sales of nicotinamide adenine dinucleotide supplements through the specialty stores channel are projected to grow significantly at a CAGR of 14.8% from 2026 to 2033. Specialty stores are supported by consumers seeking expert guidance when selecting nicotinamide adenine dinucleotide supplements, particularly for unfamiliar or premium formulations. In-store staff can explain product composition, usage, quality certifications, and differences between NAD-related ingredients. These outlets also provide consumers with an opportunity to examine packaging and product authenticity before purchase. Premium wellness stores can strengthen consumer confidence through curated product portfolios and established supplier relationships. The growing interest in personalized nutrition and targeted wellness products can further support demand through specialist-led purchasing experiences.
Regional Insights
Asia Pacific dominated the market, accounting for a revenue share of 49.0% and is the fastest CAGR of 15.3% in 2025. The nicotinamide adenine dinucleotide supplements market in the Asia Pacific is being driven by expanding health awareness and increasing interest in longevity, which is creating a broader consumer base for NAD-related products. Rapid e-commerce development is improving accessibility, particularly in markets where specialty supplement retail remains less developed. Aging populations and growing adoption of preventive nutrition are reinforcing interest in cellular-health products. Product innovation combining NAD precursors with vitamins, antioxidants, and other functional ingredients is also creating opportunities for localized offerings.
To learn more about this report,Download Free Sample Report
China Nicotinamide Adenine Dinucleotide Supplements Market Trends
China led the Asia Pacific nicotinamide adenine dinucleotide supplements market in 2025, holding the largest market share with 45.9% of the region’s total revenue. China is being driven by a large health-conscious consumer population and increasing interest in premium wellness, longevity, and preventive nutrition. Expansion of e-commerce and digital health platforms is making specialized supplements more accessible to urban consumers. Local manufacturers are increasingly developing formulations that combine NAD precursors with complementary functional ingredients. Growing demand for personalized and premium wellness solutions is encouraging product differentiation, while regulatory requirements remain an important consideration for market entry and commercialization.
North America Nicotinamide Adenine Dinucleotide Supplements Market Trends
The North America nicotinamide adenine dinucleotide supplements market accounted for a market share of 22.2% in 2025. The market is driven by strong consumer awareness of healthy aging, cellular health, energy metabolism, and longevity, which is supporting demand for NAD-focused supplements. The region has a mature nutraceutical ecosystem with established supplement brands, practitioner networks, specialty retailers, and digital sales channels. Ongoing research into NAD precursors such as NR and NMN is also encouraging interest in science-backed formulations. Premium consumers increasingly look for ingredient transparency, third-party testing, and clinically supported positioning.
The U.S. led the North American nicotinamide adenine dinucleotide supplements market in 2025, holding the largest market share with 89.5% of the region’s total revenue. The Nicotinamide Adenine Dinucleotide Supplements market in the U.S. is driven by strong consumer spending on preventive wellness and growing interest in longevity-oriented nutrition. A large ecosystem of supplement companies, wellness clinics, healthcare practitioners, and digital health platforms provides multiple routes for NAD-related products to reach consumers. Demand is also supported by interest in personalized nutrition and formulations targeting cellular energy and healthy aging. In August 2026, Lemme launched its NAD+ Healthy Aging & Skin Longevity supplement for women, featuring NMN and antioxidants. Priced at USD 50, it is marketed to support healthy aging, energy, mental clarity, and skin radiance. Product differentiation through formulation technology, quality verification, and scientific substantiation is becoming increasingly important.
Europe Nicotinamide Adenine Dinucleotide Supplements Market Trends
The European nicotinamide adenine dinucleotide supplements market is projected to grow at a CAGR of 14.3% in 2025. The European demand is supported by increasing interest in preventive healthcare, healthy aging, and evidence-based nutritional solutions. Consumers tend to place considerable emphasis on product safety, ingredient quality, transparent labeling, and scientifically supported claims. Pharmacy and specialist wellness channels provide opportunities for NAD products to reach consumers seeking professionally positioned supplements. The region's regulatory environment also encourages manufacturers to focus on compliant formulations and stronger substantiation of product benefits.
Germany led the European nicotinamide adenine dinucleotide supplements market in 2025, holding the largest market share with 24.8% of the region’s total revenue. Germany's market is supported by strong consumer interest in preventive nutrition, healthy aging, and high-quality nutraceutical products. Consumers generally show a preference for products with transparent composition, reliable manufacturing standards, and scientifically supported positioning. The country's established pharmacy and health-retail infrastructure can improve access to specialized supplements. Demand for clinically oriented and compliant NAD-precursor formulations can also benefit from Germany's emphasis on product quality and regulatory standards.
Central & South America Nicotinamide Adenine Dinucleotide Supplements Market Trends
The Central & South America nicotinamide adenine dinucleotide supplements market is projected to grow at a CAGR of 14.6% from 2026 to 2033. The nicotinamide adenine dinucleotide supplements market in Central & South America is fuled by growing wellness awareness and expansion of the middle-class consumer base are creating opportunities for specialized nutritional supplements. Fitness communities, wellness centers, and longevity-focused services can help introduce NAD-related products to consumers seeking energy and healthy-aging solutions. Cross-border e-commerce and specialty distribution can improve availability where domestic product portfolios are limited. Demand is also likely to be concentrated initially among higher-income urban consumers who are more receptive to premium wellness products.
Middle East & Africa Nicotinamide Adenine Dinucleotide Supplements Market Trends
The Middle East & Africa nicotinamide adenine dinucleotide supplements market is expected to grow at a CAGR of 15.1% from 2026 to 2033. The Middle East & Africa market benefits from increasing health and wellness awareness, which is supporting interest in premium nutritional and longevity-oriented products. Affluent consumers, particularly in major urban markets, provide a customer base for higher-value supplements with science-focused positioning. Advanced private healthcare and wellness infrastructure can facilitate exposure to NAD-related products through specialist practitioners and wellness centers. Growing digital commerce and premium healthcare services can further expand access, although affordability and market fragmentation remain relevant considerations.
Key Nicotinamide Adenine Dinucleotide Company Insights
The nicotinamide adenine dinucleotide supplements industry is characterized by a mix of established science-focused supplement companies, specialized longevity brands, and emerging direct-to-consumer players. Key companies include Niagen Bioscience, Elysium Health, Thorne, Life Extension, Renue by Science, Wonderfeel, Codeage, and ProHealth Longevity. Competition is increasingly centered on clinical evidence, ingredient quality, formulation technology, bioavailability, and differentiated delivery formats rather than product availability alone. Companies are also expanding their portfolios across NR, NMN, and combination formulations to address cellular health, energy, and healthy-aging applications.
To learn more about this report,Download Free Sample Report
Key Nicotinamide Adenine Dinucleotide Supplements Companies
The following key companies have been profiled for this study on the nicotinamide adenine dinucleotide supplements market:
-
Elysium Health
-
Niagen Bioscience, Inc.
-
Life Extension
-
Wonderfeel
-
Lemme (KK Nutrition, Inc.).
-
Core Med Science Ingredients
-
Nutricost.
-
RENUE BY SCIENCE, Inc.
-
Codeage LLC
-
Cata-Kor
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Niagen Bioscience, Inc., Elysium Health)
- Build science-led brands, expand clinical evidence, and broaden omnichannel distribution.
- Strong research credentials, patented ingredients, established consumer trust, and wider distribution.
- Premium pricing and dependence on sustained consumer interest in healthy-aging claims.
Emerging Players (Wonderfeel)
- Differentiate through NMN, liposomal delivery, specialized formulations, and DTC-focused models.
- Faster product innovation, niche longevity positioning, and formulation flexibility.
- Lower brand recognition and smaller distribution footprint versus established players.
Recent Developments
-
In September 2026, Vitafusion introduced its Vital NMN Gummies in a Tropical Glow flavor, delivering 300 mg of NMN per serving to promote NAD+ levels, cellular wellness, energy, and metabolic health. The “Aging? Love It.” TikTok-led campaign focuses on younger health-conscious audiences and presents gummies as an easy-to-use alternative to conventional NMN capsules.
-
In August 2026, Niagen Bioscience expanded Tru Niagen’s retail presence through GNC and Sam’s Club, reaching nearly 300 locations across 44 U.S. states and offering multiple product formats. The expansion across physical stores and e-commerce platforms demonstrates how specialized health-and-wellness retail and digital channels are improving access to NAD+-related supplements and supporting broader consumer penetration.
-
In June 2026, Gundry MD launched Elevate NAD+, an NMN supplement featuring patent-pending acid-resistant beadlet technology designed to improve NMN stability during storage and digestion. The product combines NMN with nicotinamide riboside, liposomal botanicals, and adaptogenic ingredients to support NAD+ levels and healthy cellular aging.
Nicotinamide Adenine Dinucleotide Supplements Market Report Scope
Report Attribute
Details
Market size in 2025
USD 2.8 billion
Market value size in 2026
USD 3.2 billion
Revenue Forecast in 2033
USD 8.5 billion
Growth Rate (Revenue)
CAGR of 14.8% from 2026 to 2033
Actuals
2021 - 2025
Forecast period
2026 - 2033
Quantitative (Revenue) units
Revenue in USD million and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Form, Distribution Channel
Regional Scope
North America, Europe, Asia-Pacific, Central & South America, Middle East & Africa
Country scope
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, Japan, India, Australia & New Zealand, South Korea, Brazil, South Africa
Key companies profiled
Elysium Health, Niagen Bioscience, Inc., Life Extension, Wonderfeel, Lemme (KK Nutrition, Inc.), Core Med Science, Nutricost, RENUE BY SCIENCE, Inc., Codeage LLC, Cata-Kor
Customization scope
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Nicotinamide Adenine Dinucleotide Supplements Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide supplements market report on the basis of form, distribution channel, and region.
To learn more about this report,Download Free Sample Report
-
Form Outlook (Revenue, USD Million, 2021 - 2033)
-
Capsules/ Tablets
-
Gummies
-
Powders
-
Others
-
-
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
-
Hypermarkets & Supermarkets
-
Pharmacies & Drug Stores
-
Specialty Stores
-
Online
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia & New Zealand
-
South Korea
-
-
Central & South America
-
Brazil
-
-
Middle East & Africa
-
South Africa
-
-
Research Methodology
The nicotinamide adenine dinucleotide supplements market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each nicotinamide adenine dinucleotide supplements segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Form
Revenue capture definition
Capsules/ Tablets
Nicotinamide Adenine Dinucleotide Supplements in capsule and tablet formats generate revenue through standardized, convenient dosage forms sold across pharmacies, health stores, e-commerce platforms, and practitioner-led channels. Revenue is captured through individual packs, multi-month supplies, and premium formulations with higher-strength or enhanced ingredient combinations. Repeat consumption can support recurring purchases as consumers follow daily supplementation routines. Manufacturers can further capture value through branded formulations, clinically positioned ingredients, and specialized delivery technologies.
Gummies
NAD gummies generate revenue by combining NAD-related ingredients with an easy-to-consume format that appeals to consumers who prefer alternatives to conventional pills. Revenue is captured through retail packs, online sales, wellness platforms, and subscription-based purchasing where offered. Manufacturers can differentiate products through flavors, nutritional combinations, sugar-free formulations, and targeted wellness positioning. The format can support premium pricing when convenience, taste, and formulation attributes are emphasized.
Powders
NAD supplement powders generate revenue through flexible formulations that can be mixed with water, beverages, smoothies, or other functional nutrition products. Sales are captured through jars, sachets, single-dose packs, and larger-volume formats distributed through online and specialty health channels. Manufacturers can increase product value by combining NAD precursors with complementary nutrients and functional ingredients. Customizable serving sizes and suitability for wellness routines provide additional opportunities for product differentiation and repeat consumption.
Others
Other forms include emerging delivery formats such as liquids, sublingual products, lozenges, sprays, and specialized formulations designed to provide alternative consumption experiences. Revenue is generated through differentiated products distributed via specialty retailers, online platforms, wellness providers, and selected healthcare-oriented channels. Companies can capture additional value by emphasizing convenience, targeted delivery, formulation innovation, or specialized use cases. These formats allow manufacturers to address consumers seeking alternatives to traditional oral supplement products.
Estimation Model
Layer
Question
Description
Consumption Profile Layer
Who consumes NAD supplements?
Health-conscious adults, longevity-focused consumers, biohackers, fitness enthusiasts, and consumers seeking energy or healthy-aging support.
Market Reach Layer
Where can consumers access them?
Primarily e-commerce/D2C, marketplaces, pharmacies, specialty health stores, and wellness clinics.
Purchase & Retention Layer
What drives repeat purchases?
Driven by perceived efficacy, product trust, ingredient transparency, convenience, scientific evidence, and subscription/replenishment models.
Value Generation Layer
How is revenue generated?
Generated through premium formulations, differentiated delivery formats, science-backed positioning, recurring subscriptions, and higher-value longevity/wellness products.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Global NAD⁺ Supplement Brand & Product Landscape Assessment
Assessed NAD⁺ precursor categories including NMN, NR, nicotinamide, and combination formulations, along with dosage formats, positioning, target consumer segments, and product differentiation.
Identifies portfolio gaps, emerging formulation concepts, and opportunities to establish differentiated positioning in the NAD⁺ wellness space.
Global NAD⁺ Supplement Channel & Commercial Assessment
Evaluated e-commerce, specialty health, practitioner-led, and other distribution channels, including price architecture, consumer access models, and commercial positioning.
Supports channel prioritization, pricing decisions, route-to-market planning, and identification of scalable commercial opportunities.
Global NAD⁺ Supplement Regulatory & Scientific Environment Assessment
Reviewed regulatory considerations, ingredient status, labeling expectations, permissible claims, safety considerations, and the evolving human evidence base for NAD⁺-related ingredients across key markets.
Helps anticipate market-entry constraints, strengthen compliance planning, and align product claims and launch strategies with the evolving regulatory and scientific landscape.
Frequently Asked Questions About This Report
Middle East & Africa is the fastest-growing region over the forecast period.
Key players include Elysium Health, Niagen Bioscience, Inc., Life Extension, Wonderfeel, Lemme (KK Nutrition, Inc.), Core Med Science, Nutricost, RENUE BY SCIENCE, Inc., Codeage LLC, Cata-Kor
The global nicotinamide adenine dinucleotide supplements market size was valued at USD 2.8 billion in 2025 and is estimated at USD 3.2 billion in 2026.
The global nicotinamide adenine dinucleotide supplements market is expected to grow at a CAGR of 14.8% from 2026 to 2033, reaching USD 8.5 billion by 2033.
Capsules/tables dominated the market with 61.1% revenue share in 2025, while gummies is the fastest-growing segment.
Asia Pacific dominated the market, accounting for a revenue share of 49.0% in 2025.
Key factors include increasing consumer interest in healthy ageing, cellular energy production, and preventive wellness, driving demand for NAD+ boosters such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).
Online channels dominated the market with 48.3% revenue share in 2025, while specialty stores channels segment is the fastest growing distribution channel.
About the Author(s)
Nutraceuticals & Functional Foods Research Team
Consumer Goods · Nutraceuticals & Functional FoodsThis report was authored by the nutraceuticals & functional foods research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the nutraceuticals & functional foods segment of the consumer goods industry. All findings are based on proprietary consumer goods databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.